Serum cardiac troponin-I is superior to troponin-T as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Buiten, Maurits S ^a   De Bie, Mihály K ^a   Rotmans, Joris I ^a   Dekker, Friedo W ^a   Van Buren, Marjolijn ^b   Rabelink, Ton J ^a   Cobbaert, Christa M ^a   Schalij, Martin J ^a   Van Der Laarse, Arnoud ^a   Jukema, J Wouter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA City Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS INDEX; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DIAGNOSIS; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS;

AGED; BIOMARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; TROPONIN I; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84941892562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134245     Document Type: Article

References (42)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US Renal Data System 2013 Annual Data Report. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2014; 63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001 PMID: 24360288
2. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130(25):2354-94. doi: 10.1161/CIR. 0000000000000133 PMID: 25249586
3. Wu AH, Ford L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clinica chimica acta; international journal of clinical chemistry. 1999; 284(2):161-74. PMID: 10451243
4. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002; 106(23):2941-5. PMID: 12460876
5. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005; 112 (20):3088-96. doi: 10.1161/CIRCULATIONAHA.105.560128 PMID: 16286604
6. Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, et al. Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Annals of internal medicine. 2014; 161(7):491-501. doi: 10. 7326/M14-0743 PMID: 25111499
7. Coudrey L. The troponins. Archives of internal medicine. 1998; 158(11):1173-80. PMID: 9625396
8. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, et al. Sensitive troponins-which suits better for hemodialysis patients? Associated factors and prediction of mortality. PloS one. 2012; 7 (10):e47610. doi: 10.1371/journal.pone.0047610 PMID: 23077650; PubMed Central PMCID: PMC3471860
9. Kumar N, Michelis MF, DeVita MV, Panagopoulos G, Rosenstock JL. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011; 26(2):665-70. doi: 10.1093/ndt/gfq442 PMID: 20656755
10. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Annals of clinical biochemistry. 2009; 46(Pt 4):283-90. doi: 10.1258/acb.2009.008197 PMID: 19454537
11. Cardinaels EP, Mingels AM, van Rooij T, Collinson PO, Prinzen FW, van Dieijen-Visser MP. Timedependent degradation pattern of cardiac troponin T following myocardial infarction. Clinical chemistry. 2013; 59(7):1083-90. doi: 10.1373/clinchem.2012.200543 PMID: 23536511
12. Wu AH, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clinical chemistry. 1998; 44(6 Pt 1):1198-208. PMID: 9625043
13. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004; 109 (1):23-5. doi: 10.1161/01.CIR.0000109483.45211.8F PMID: 14691043
14. Gaze DC, Collinson PO. Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis. Open heart. 2014; 1(1):e000108. doi: 10.1136/openhrt-2014-000108 PMID: 25332816; PubMed Central PMCID: PMC4195923
15. de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, et al. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial-a prospective pilot study. Current medical research and opinion. 2008; 24 (8):2151-7. doi: 10.1185/03007990802237343 PMID: 18561878
16. Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association. 2007; 22 Suppl 2:ii45-87. doi: 10.1093/ndt/gfm020 PMID: 17507426
17. Krintus M, Kozinski M, Boudry P, Capell NE, Koller U, Lackner K, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2014; 52(11):1657-65. doi: 10.1515/cclm-2014-0107 PMID: 24897400
18. de Bie MK, Buiten MS, Gaasbeek A, Boogers MJ, Roos CJ, Schuijf JD, et al. CT coronary angiography is feasible for the assessment of coronary artery disease in chronic dialysis patients, despite high average calcium scores. PloS one. 2013; 8(7):e67936. doi: 10.1371/journal.pone.0067936 PMID: 23874471; PubMed Central PMCID: PMC3707871
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2005; 18(12):1440-63. doi: 10.1016/j.echo.2005.10.005 PMID: 16376782
20. Wang AY, Wai-Kei Lam C. The diagnostic utility of cardiac biomarkers in dialysis patients. Seminars in dialysis. 2012; 25(4):388-96. doi: 10.1111/j.1525-139X.2012.01099.x PMID: 22748194
21. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA: the journal of the American Medical Association. 2010; 304(22):2503-12. doi: 10.1001/jama. 2010.1768 PMID: 21139111
22. Mishra RK, Li Y, DeFilippi C, Fischer MJ, Yang W, Keane M, et al. Association of cardiac troponin T with left ventricular structure and function in CKD. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2013; 61(5):701-9. doi: 10.1053/j.ajkd.2012.11.034 PMID: 23291148; PubMed Central PMCID: PMC3627820
23. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney international. 2002; 62(5):1884-90. doi: 10.1046/j.1523-1755.2002.00641.x PMID: 12371993
24. Chin CW, Shah AS, McAllister DA, Joanna Cowell S, Alam S, Langrish JP, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. European heart journal. 2014; 35(34):2312-21. doi: 10.1093/eurheartj/ ehu189 PMID: 24829362; PubMed Central PMCID: PMC4156973
25. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2002; 40(1):68-75 doi: 10.1053/ajkd.2002.33914 PMID: 12087563
26. Lowbeer C, Ottosson-Seeberger A, Gustafsson SA, Norrman R, Hulting J, Gutierrez A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association. 1999; 14(8):1948-55. PMID: 10462276
27. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and Creactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA: the journal of the American Medical Association. 2003; 290 (3):353-9. doi: 10.1001/jama.290.3.353 PMID: 12865376
28. Hayashi T, Obi Y, Kimura T, Iio K, Sumitsuji S, Takeda Y, et al. Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association. 2008; 23(9):2936-42. doi: 10.1093/ndt/gfn181 PMID: 18403432
29. Jung HH, Ma KR, Han H. Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2004; 19(12):3117-23. doi: 10.1093/ndt/gfh488 PMID: 15546893
30. Cobbaert CM, Bootsma M, Boden H, Ahmed TA, Hoogslag GE, Romijn FP, et al. Confounding factors in the relation between high sensitivity cardiac troponin T levels in serum and infarct size of patients with first ST-elevation myocardial infarction. International journal of cardiology. 2014; 172(1):e3-5. doi: 10.1016/j.ijcard.2013.12.141 PMID: 24439874
31. Ziebig R, Lun A, Hocher B, Priem F, Altermann C, Asmus G, et al. Renal elimination of troponin T and troponin I. Clinical chemistry. 2003; 49(7):1191-3. PMID: 12816921
32. Moore JK, Craig DG, Pryde EA, Walker SW, Beckett GJ, Hayes PC, et al. Persistently elevated troponin I in paracetamol hepatotoxicity: association with liver injury, organ failure, and outcome. Clinical toxicology. 2013; 51(7):532-9. doi: 10.3109/15563650.2013.816853 PMID: 23829708
33. Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clinical chemistry. 2000; 46(9):1345-50. PMID: 10973864
34. Ungerer JP, Marquart L, O'Rourke PK, Wilgen U, Pretorius CJ. Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: implications for harmonization. Clinical chemistry. 2012; 58 (1):274-83. doi: 10.1373/clinchem.2011.175059 PMID: 22125306
35. Franekova J, Blaha M, Belohoubek J, Kotrbata M, Secnik P Jr, Kubicek Z, et al. A clinical and laboratory approach used to elucidate discordant results of high-sensitivity troponin T and troponin I. Clinica chimica acta; international journal of clinical chemistry. 2015; 446:128-31. doi: 10.1016/j.cca.2015.03.046 PMID: 25896964
36. Wong SL, Isserow S, Pudek M. Macrotroponin causing elevation in cardiac troponin I. The Canadian journal of cardiology. 2014; 30(8):956 e5-6. doi: 10.1016/j.cjca.2014.03.037 PMID: 24999169
37. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clinical chemistry. 2005; 51(5):839-47. doi:10. 1373/clinchem.2004.040063 PMID: 15718489
38. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. The New England journal of medicine. 2005; 352(1):98-100. doi: 10.1056/NEJM200501063520123 PMID: 15635126
39. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation. 2006; 114 (16):1693-702. doi: 10.1161/CIRCULATIONAHA.106.635664 PMID: 17015788
40. Basit M, Bakshi N, Hashem M, Allebban Z, Lawson N, Rosman HS, et al. The effect of freezing and long-term storage on the stability of cardiac troponin T. American journal of clinical pathology. 2007; 128(1):164-7. doi: 10.1309/LR7FC0LUGLHT8X6J PMID: 17580285
41. Gillis JM, Dunselman P, Jarausch J, de Jong N, Cobbaert CM. Preanalytical storage does not affect 99th percentile cardiac troponin T concentrations measured with a high-sensitivity assay. Clinical chemistry. 2013; 59(2):442-3. doi: 10.1373/clinchem.2012.192211 PMID: 23220225
42. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. The New England journal of medicine. 2009; 361 (9):858-67. doi: 10.1056/NEJMoa0900428 PMID: 19710484